{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T23:28:05Z","timestamp":1777937285257,"version":"3.51.4"},"reference-count":167,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,4,20]],"date-time":"2022-04-20T00:00:00Z","timestamp":1650412800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,4,20]],"date-time":"2022-04-20T00:00:00Z","timestamp":1650412800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Humanit Soc Sci Commun"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Genetic engineering has provided humans the ability to transform organisms by direct manipulation of genomes within a broad range of applications including agriculture (e.g., GM crops), and the pharmaceutical industry (e.g., insulin production). Developments within the last 10 years have produced new tools for genome editing (e.g., CRISPR\/Cas9) that can achieve much greater precision than previous forms of genetic engineering. Moreover, these tools could offer the potential for interventions on humans and for both clinical and non-clinical purposes, resulting in a broad scope of applicability. However, their promising abilities and potential uses (including their applicability in humans for either somatic or heritable genome editing interventions) greatly increase their potential societal impacts and, as such, have brought an urgency to ethical and regulatory discussions about the application of such technology in our society. In this article, we explore different arguments (pragmatic, sociopolitical and categorical) that have been made in support of or in opposition to the new technologies of genome editing and their impact on the debate of the permissibility or otherwise of human heritable genome editing interventions in the future. For this purpose, reference is made to discussions on genetic engineering that have taken place in the field of bioethics since the 1980s. Our analysis shows that the dominance of categorical arguments has been reversed in favour of pragmatic arguments such as safety concerns. However, when it comes to involving the public in ethical discourse, we consider it crucial widening the debate beyond such pragmatic considerations. In this article, we explore some of the key categorical as well sociopolitical considerations raised by the potential uses of heritable genome editing interventions, as these considerations underline many of the societal concerns and values crucial for public engagement. We also highlight how pragmatic considerations, despite their increasing importance in the work of recent authoritative sources, are unlikely to be the result of progress on outstanding categorical issues, but rather reflect the limited progress on these aspects and\/or pressures in regulating the use of the technology.<\/jats:p>","DOI":"10.1057\/s41599-022-01147-y","type":"journal-article","created":{"date-parts":[[2022,4,20]],"date-time":"2022-04-20T10:02:51Z","timestamp":1650448971000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":55,"title":["Beyond safety: mapping the ethical debate on heritable genome editing interventions"],"prefix":"10.1057","volume":"9","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0435-6296","authenticated-orcid":false,"given":"Mara","family":"Almeida","sequence":"first","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1676-1694","authenticated-orcid":false,"given":"Robert","family":"Ranisch","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2022,4,20]]},"reference":[{"issue":"2","key":"1147_CR1","first-page":"137","volume":"12","author":"N Agar","year":"1998","unstructured":"Agar N (1998) Liberal eugenics. Public Aff Q 12(2):137\u2013155","journal-title":"Public Aff Q"},{"key":"1147_CR2","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1093\/emph\/eoz026","volume":"1","author":"M Almeida","year":"2019","unstructured":"Almeida M, Diogo R (2019) Human enhancement: genetic engineering and evolution. Evol Med Public Health 1:183\u2013189. https:\/\/doi.org\/10.1093\/emph\/eoz026","journal-title":"Evol Med Public Health"},{"issue":"3","key":"1147_CR3","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1093\/jmp\/10.3.275","volume":"10","author":"WF Anderson","year":"1985","unstructured":"Anderson WF (1985) Human Gene Therapy: scientific and ethical considerations. J Med Philos 10(3):275\u2013291. https:\/\/doi.org\/10.1093\/jmp\/10.3.275","journal-title":"J Med Philos"},{"issue":"4","key":"1147_CR4","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1016\/j.tibtech.2019.12.022","volume":"38","author":"R Andorno","year":"2020","unstructured":"Andorno R, Baylis F, Darnovsky M, Dickenson D, Haker H, Hasson K et al. (2020) Geneva statement on heritable human genome editing: the need for course correction. Trends Biotechnol 38(4):351\u2013354","journal-title":"Trends Biotechnol"},{"key":"1147_CR5","volume-title":"Bioethics: crossing human rights and health law boundaries","author":"GJ Annas","year":"2005","unstructured":"Annas GJ (2005) Bioethics: crossing human rights and health law boundaries. Oxford University Press, New York, NY"},{"issue":"2\u20133","key":"1147_CR6","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1017\/S009885880001162X","volume":"28","author":"GJ Annas","year":"2002","unstructured":"Annas GJ, Andrews LB, Isasi RM (2002) Protecting the endangered human: toward an international treaty prohibiting cloning and inheritable alterations. Am J Law Med 28(2\u20133):151\u2013178","journal-title":"Am J Law Med"},{"issue":"1","key":"1147_CR7","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1186\/1477-7827-12-108","volume":"12","author":"M Araki","year":"2014","unstructured":"Araki M, Ishii T (2014) International regulatory landscape and integration of corrective genome editing into in vitro fertilization. Reprod Biol Endocrinol 12(1):108\u2013120","journal-title":"Reprod Biol Endocrinol"},{"key":"1147_CR10","volume-title":"Disability and genetics: a disability critique of pre-natal testing and pre-implantation genetic diagnosis. eLS","author":"A Asch","year":"2012","unstructured":"Asch A, Barlevy D (2012) Disability and genetics: a disability critique of pre-natal testing and pre-implantation genetic diagnosis. eLS. Wiley, Chichester"},{"key":"1147_CR13","volume-title":"Routledge companion to bioethics","author":"A Asch","year":"2015","unstructured":"Asch A, Wasserman D (2015) Reproductive testing for disability. In: Arras JD, Fenton E, Kukla R (eds.) Routledge companion to bioethics. Routledge, London"},{"issue":"6230","key":"1147_CR17","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1126\/science.aab1028","volume":"348","author":"D Baltimore","year":"2015","unstructured":"Baltimore D, Berg P, Botchan M, Carroll D, Charo RA, Church G et al. (2015) A prudent path forward for genomic engineering and germline gene modification. Science 348(6230):36. https:\/\/doi.org\/10.1126\/science.aab1028","journal-title":"Science"},{"key":"1147_CR19","unstructured":"Baltimore D, Baylis F, Berg P et al. (2015) On human gene editing: international summit statement. News release, December 3, International summit on human gene editing. http:\/\/www8.nationalacademies.org\/onpinews\/newsitem.aspx?RecordID=12032015a"},{"issue":"17092","key":"1147_CR20","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/nmicrobiol.2017.92","volume":"2","author":"R Barrangou","year":"2017","unstructured":"Barrangou R, Horvath P (2017) A decade of discovery: CRISPR functions and applications. Nat Microbiol 2(17092):1\u20139. https:\/\/doi.org\/10.1038\/nmicrobiol.2017.92","journal-title":"Nat Microbiol"},{"key":"1147_CR21","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1007\/s11569-016-0259-0","volume":"10","author":"M Baumann","year":"2016","unstructured":"Baumann M (2016) CRISPR\/Cas9 genome editing: new and old ethical issues arising from a revolutionary technology. Nanoethics 10:139\u201359","journal-title":"Nanoethics"},{"key":"1147_CR22","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.rbms.2017.01.001","volume":"3","author":"MJ Bayefsky","year":"2016","unstructured":"Bayefsky MJ (2016) Comparative preimplantation genetic diagnosis policy in Europe and the USA and its implications for reproductive tourism. Reprod Biomed Soc Online 3:41\u201347","journal-title":"Reprod Biomed Soc Online"},{"issue":"2","key":"1147_CR23","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1076\/jmep.28.2.131.14210","volume":"28","author":"K Bayertz","year":"2003","unstructured":"Bayertz K (2003) Human nature: how normative might it be? J Med Philos 28(2):131\u2013150. https:\/\/doi.org\/10.1076\/jmep.28.2.131.14210","journal-title":"J Med Philos"},{"key":"1147_CR24","doi-asserted-by":"publisher","first-page":"0103","DOI":"10.1038\/s41562-017-0103","volume":"1","author":"F Baylis","year":"2017","unstructured":"Baylis F (2017) Human germline genome editing and broad societal consensus. Nat Hum Behav 1:0103","journal-title":"Nat Hum Behav"},{"key":"1147_CR25","first-page":"42","volume":"35","author":"F Baylis","year":"2019","unstructured":"Baylis F (2019) Human genome editing: our future belongs to all of us. Issues Sci Technol 35:42\u201344","journal-title":"Issues Sci Technol"},{"issue":"12","key":"1147_CR26","doi-asserted-by":"publisher","first-page":"2084","DOI":"10.15252\/embr.201745343","volume":"8","author":"F Baylis","year":"2017","unstructured":"Baylis F, Ikemoto L (2017) The Council of Europe and the prohibition on human germline genome editing. EMBO Rep 8(12):2084\u20132085. https:\/\/doi.org\/10.15252\/embr.201745343","journal-title":"EMBO Rep"},{"issue":"5","key":"1147_CR27","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1089\/crispr.2020.0082","volume":"3","author":"F Baylis","year":"2020","unstructured":"Baylis F, Darnovsky M, Hasson K, Krahn TM (2020) Human Germ Line and Heritable Genome Editing: the global policy landscape. CRISPR J 3(5):365\u2013377. https:\/\/doi.org\/10.1089\/crispr.2020.0082. PMID: 33095042","journal-title":"CRISPR J"},{"key":"1147_CR28","volume-title":"Principles of biomedical ethics","author":"TL Beauchamp","year":"2019","unstructured":"Beauchamp TL, Childress JF (2019) Principles of biomedical ethics. Oxford University Press, USA"},{"issue":"15","key":"1147_CR29","doi-asserted-by":"publisher","first-page":"1406","DOI":"10.1056\/NEJMp1602010","volume":"374","author":"RJ Blendon","year":"2016","unstructured":"Blendon RJ, Gorski MT, Benson JM (2016) The public and the gene-editing revolution. New Engl J Med 374(15):1406\u20131411. https:\/\/doi.org\/10.1056\/NEJMp1602010","journal-title":"New Engl J Med"},{"issue":"6","key":"1147_CR30","doi-asserted-by":"publisher","first-page":"941","DOI":"10.1002\/mgg3.463","volume":"6","author":"FK Boardman","year":"2018","unstructured":"Boardman FK, Hale R (2018) How do genetically disabled adults view selective reproduction? Impairment, identity, and genetic screening. Mol Genet Genom Med 6(6):941\u2013956","journal-title":"Mol Genet Genom Med"},{"issue":"5","key":"1147_CR31","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1038\/nbt.3227","volume":"33","author":"KS Bosley","year":"2015","unstructured":"Bosley KS, Botchan M, Bredenoord AL, Carroll D, Charo RA, Charpentier E et al. (2015) CRISPR germline engineering: the community speaks. Nat Biotechnol 33(5):478\u2013486. https:\/\/doi.org\/10.1038\/nbt.3227","journal-title":"Nat Biotechnol"},{"key":"1147_CR32","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1038\/s41436-019-0696-6","volume":"22","author":"JR Botkin","year":"2019","unstructured":"Botkin JR (2019) The case for banning heritable genome editing. Genet Med 22:487\u2013489","journal-title":"Genet Med"},{"issue":"2","key":"1147_CR33","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1089\/crispr.2017.0024","volume":"1","author":"C Brokowski","year":"2018","unstructured":"Brokowski C (2018) Do CRISPR germline ethics statements cut it? CRISPR J 1(2):115\u2013125. https:\/\/doi.org\/10.1089\/crispr.2017.0024","journal-title":"CRISPR J"},{"key":"1147_CR34","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1017\/S0265052500003447","volume":"13","author":"A Buchanan","year":"1996","unstructured":"Buchanan A (1996) Choosing who will be disabled: genetic intervention and the morality of inclusion. Soc Philos Policy 13:18\u201346","journal-title":"Soc Philos Policy"},{"key":"1147_CR35","doi-asserted-by":"crossref","unstructured":"Buchanan A, Brock DW, Daniels N, Wikler D (2000) From chance to choice: genetics and justice. Cambridge University Press","DOI":"10.1017\/CBO9780511806940"},{"key":"1147_CR36","first-page":"473","volume":"26","author":"Z Calo","year":"2012","unstructured":"Calo Z (2012) Human dignity and health law: personhood in recent bioethical debates. Notre Dame J Law Ethics Public Policy 26:473\u2013499","journal-title":"Notre Dame J Law Ethics Public Policy"},{"issue":"4","key":"1147_CR37","doi-asserted-by":"publisher","first-page":"S66","DOI":"10.1007\/BF03351288","volume":"21","author":"L Carter","year":"2002","unstructured":"Carter L (2002) The ethics of germ line gene manipulation\u2014a five dimensional debate. Monash Bioeth Rev 21(4):S66\u2013S81. https:\/\/doi.org\/10.1007\/BF03351288","journal-title":"Monash Bioeth Rev"},{"issue":"2","key":"1147_CR38","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1007\/s11019-017-9793-y","volume":"21","author":"G Cavaliere","year":"2018","unstructured":"Cavaliere G (2018) Genome editing and assisted reproduction: curing embryos, society or prospective parents? Med Health Care Phil 21(2):215\u201325","journal-title":"Med Health Care Phil"},{"issue":"70","key":"1147_CR39","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1146\/annurev-med-112717-094629","volume":"27","author":"BS Coller","year":"2019","unstructured":"Coller BS (2019) Ethics of human genome editing. Annu Rev Med 27(70):289\u2013305. https:\/\/doi.org\/10.1146\/annurev-med-112717-094629","journal-title":"Annu Rev Med"},{"key":"1147_CR9","volume-title":"Convention for the protection of human rights and dignity of the human being with regard to the application of biology and medicine: convention on human rights and biomedicine","author":"Council of Europe","year":"1997","unstructured":"Council of Europe (1997) Convention for the protection of human rights and dignity of the human being with regard to the application of biology and medicine: convention on human rights and biomedicine. COE, Oviedo"},{"key":"1147_CR40","unstructured":"Collins, F. (2015) Director, National Institutes of Health, https:\/\/www.nih.gov\/about-nih\/who-we-are\/nih-director\/statements\/statement-nih-funding-research-using-gene-editing-technologieshuman-embryos"},{"key":"1147_CR41","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1126\/science.1231143","volume":"339","author":"L Cong","year":"2013","unstructured":"Cong L, Ran FA, Cox D, Lin S, Barretto R, Habib N et al. (2013) Multiplex genome engineering using CRISPR\/Cas systems. Science 339:819\u2013823","journal-title":"Science"},{"issue":"7","key":"1147_CR42","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1038\/ng.862","volume":"43","author":"DF Conrad","year":"2011","unstructured":"Conrad DF, Keebler JE, DePristo MA, Lindsay SJ, Zhang Y, Casals F et al. (2011) Variation in genome-wide mutation rates within and between human families. Nat Genet 43(7):712\u20134. https:\/\/doi.org\/10.1038\/ng.862","journal-title":"Nat Genet"},{"issue":"4","key":"1147_CR43","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1007\/s10728-005-8127-z","volume":"13","author":"DE Cutas","year":"2005","unstructured":"Cutas DE (2005) Looking for the meaning of dignity in the bioethics convention and the cloning protocol. Health Care Anal 13(4):303\u2013313","journal-title":"Health Care Anal"},{"issue":"8","key":"1147_CR44","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1080\/15265161.2020.1783024","volume":"20","author":"B Cwik","year":"2020","unstructured":"Cwik B (2020) Revising, correcting, and transferring genes. Am J Bioeth 20(8):7\u201318","journal-title":"Am J Bioeth"},{"issue":"7760","key":"1147_CR45","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1038\/d41586-019-01770-x","volume":"570","author":"D Cyranoski","year":"2019","unstructured":"Cyranoski D (2019) Russian biologist plans more CRISPR-edited babies. Nature 570(7760):145\u2013147","journal-title":"Nature"},{"key":"1147_CR46","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1056\/NEJMp1900504","volume":"380","author":"GQ Daley","year":"2019","unstructured":"Daley GQ, Lovell-Badge R, Steffann J (2019) After the storm\u2014a responsible path for genome editing. N Engl J Med 380:897\u2013899","journal-title":"N Engl J Med"},{"issue":"1","key":"1147_CR8","first-page":"24","volume":"27","author":"M de Araujo","year":"2017","unstructured":"de Araujo M (2017) Editing the genome of human beings: CRISPR-Cas9 and the ethics of genetic enhancement. J Evol Technol 27(1):24\u201342. http:\/\/jetpress.org\/v27.1\/araujo.pdf","journal-title":"J Evol Technol"},{"key":"1147_CR47","doi-asserted-by":"publisher","first-page":"6245","DOI":"10.1073\/pnas.1503840112","volume":"112","author":"A Dance","year":"2015","unstructured":"Dance A (2015) Core concept: CRISPR gene editing. Proc Natl Acad Sci USA 112:6245\u20136246","journal-title":"Proc Natl Acad Sci USA"},{"key":"1147_CR48","volume-title":"Editing humanity: the CRISPR revolution and the new era of genome editing","author":"K Davies","year":"2020","unstructured":"Davies K (2020) Editing humanity: the CRISPR revolution and the new era of genome editing. Pegasus Books, New York, NY"},{"issue":"7","key":"1147_CR49","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1136\/jme.2010.039420","volume":"37","author":"JJ Delaney","year":"2011","unstructured":"Delaney JJ (2011) Possible people, complaints, and the distinction between genetic planning and genetic engineering. J Med Ethics 37(7):410\u2013414","journal-title":"J Med Ethics"},{"key":"1147_CR50","unstructured":"Deutscher Ethikrat, (2019) Intervening in the Human Germline. https:\/\/www.ethikrat.org\/en\/publications\/publication-details\/?tx_wwt3shop_detail%5Bproduct%5D=119&tx_wwt3shop_detail%5Baction%5D=index&tx_wwt3shop_detail%5Bcontroller%5D=Products&cHash=25e88ad52f8b75d311510a9bf7a8dc86"},{"issue":"6213","key":"1147_CR51","doi-asserted-by":"publisher","first-page":"1258096","DOI":"10.1126\/science.1258096","volume":"346","author":"JA Doudna","year":"2014","unstructured":"Doudna JA, Charpentier E (2014) Genome editing. The new frontier of genome engineering with CRISPR-Cas9. Science 346(6213):1258096. https:\/\/doi.org\/10.1126\/science.1258096","journal-title":"Science"},{"key":"1147_CR52","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1111\/bioe.12713","volume":"34","author":"K Drabiak","year":"2020","unstructured":"Drabiak K (2020) The Nuffield Council\u2019s green light for genome editing human embryos defies fundamental human rights law. Bioethics 34:223\u2013227","journal-title":"Bioethics"},{"issue":"6420","key":"1147_CR53","doi-asserted-by":"publisher","first-page":"1215","DOI":"10.1126\/science.aaw3127","volume":"362","author":"VJ Dzau","year":"2018","unstructured":"Dzau VJ, McNutt M, Bai C (2018) Wake-up call from Hong Kong. Science 362(6420):1215. https:\/\/doi.org\/10.1126\/science.aaw3127","journal-title":"Science"},{"issue":"3","key":"1147_CR109","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1007\/s12687-020-00460-w","volume":"11","author":"I de Miguel Beriain","year":"2020","unstructured":"de Miguel Beriain I (2020) Gene editing and disabled people: a response to Felicity Boardman. J Community Genet 11(3):241\u2013243","journal-title":"J Community Genet"},{"key":"1147_CR108","doi-asserted-by":"publisher","first-page":"e46789","DOI":"10.15252\/embr.201846789","volume":"19","author":"I de Miguel Beriain","year":"2018","unstructured":"de Miguel Beriain I (2018) Human dignity and gene editing. EMBO Rep 19:e46789","journal-title":"EMBO Rep"},{"issue":"4","key":"1147_CR162","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1038\/s41431-017-0077-z","volume":"26","author":"G de Wert","year":"2018","unstructured":"de Wert G, Heindryckx B, Pennings G, Clarke A, Eichenlaub-Ritter U, van El CG (2018) Responsible innovation in human germline gene editing: background document to the recommendations of ESHG and ESHRE. Eur J Hum Genet 26(4):450\u2013470. https:\/\/doi.org\/10.1038\/s41431-017-0077-z","journal-title":"Eur J Hum Genet"},{"key":"1147_CR54","unstructured":"EGE (2016) Statement on gene editing. https:\/\/ec.europa.eu\/info\/sites\/default\/files\/research_and_innovation\/ege\/gene_editing_ege_statement.pdf"},{"key":"1147_CR55","unstructured":"EGE (2021) Ethics of genome editing. https:\/\/ec.europa.eu\/info\/sites\/default\/files\/research_and_innovation\/ege\/ege_ethics_of_genome_editing-opinion_publication.pdf"},{"issue":"12","key":"1147_CR56","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1080\/15265161.2015.1104160","volume":"15","author":"NH Evitt","year":"2015","unstructured":"Evitt NH, Mascharak S, Altman RB (2015) Human germline crispr-cas modification: toward a regulatory framework. Am J Bioeth 15(12):25\u201329","journal-title":"Am J Bioeth"},{"issue":"12","key":"1147_CR57","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1080\/15265161.2018.1531160","volume":"18","author":"O Feeney","year":"2018","unstructured":"Feeney O, Cockbain J, Morrison M, Diependaele L, Van Assche K, Sterckx S (2018) Patenting foundational technologies: lessons from CRISPR and other core biotechnologies. Am J Bioeth 18(12):36\u201348","journal-title":"Am J Bioeth"},{"key":"1147_CR59","doi-asserted-by":"publisher","unstructured":"Fenton E (2008) Genetic enhancement \u2013 a threat to human rights? Bioethics 22(1):1\u20137 https:\/\/doi.org\/10.1111\/j.1467-8519.2007.00564.x","DOI":"10.1111\/j.1467-8519.2007.00564.x"},{"key":"1147_CR58","doi-asserted-by":"crossref","unstructured":"Feinberg J (1992) The child\u2019s right to an open future. In: Feinberg J (ed.) Freedom and fulfillment: philosophical essays. Princeton University Press, Princeton, pp. 6\u201397","DOI":"10.1515\/9780691218144"},{"key":"1147_CR60","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1146\/annurev-genom-091212-153509","volume":"14","author":"W Fu","year":"2013","unstructured":"Fu W, Akey JM (2013) Selection and adaptation in the human genome. Annu Rev Genom Hum Genet 14:467\u201389","journal-title":"Annu Rev Genom Hum Genet"},{"key":"1147_CR61","volume-title":"Our posthuman future: consequences of the biotechnology revolution","author":"F Fukuyama","year":"2002","unstructured":"Fukuyama F (2002) Our posthuman future: consequences of the biotechnology revolution. Picador, New York, NY"},{"issue":"7","key":"1147_CR62","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1016\/j.tibtech.2013.04.004","volume":"31","author":"T Gaj","year":"2013","unstructured":"Gaj T, Gersbach CA, Barbas III CF (2013) ZFN, TALEN, and CRISPR\/Cas-based methods for genome engineering. Trends Biotechnol 31(7):397\u2013405","journal-title":"Trends Biotechnol"},{"issue":"11","key":"1147_CR63","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.1038\/nbt.3958","volume":"35","author":"G Gaskell","year":"2017","unstructured":"Gaskell G, Bard I, Allansdottir A, da Cunha RV, Eduard P, Hampel J et al. (2017) Public views on gene editing and its uses. Nat Biotechnol 35(11):1021\u20131023. https:\/\/doi.org\/10.1038\/nbt.3958","journal-title":"Nat Biotechnol"},{"issue":"7571","key":"1147_CR64","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1038\/nature15393","volume":"526","author":"C Genomes Project","year":"2015","unstructured":"Genomes Project C et al. (2015) A global reference for human genetic variation. Nature 526(7571):68\u201374","journal-title":"Nature"},{"issue":"5","key":"1147_CR66","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1089\/crispr.2019.0038","volume":"2","author":"HT Greely","year":"2019","unstructured":"Greely HT (2019) Human germline genome editing: an assessment. CRISPR J 2(5):253\u2013265. https:\/\/doi.org\/10.1089\/crispr.2019.0038","journal-title":"CRISPR J"},{"key":"1147_CR65","doi-asserted-by":"publisher","DOI":"10.1093\/acprof:oso\/9780199290925.001.0001","volume-title":"Choosing children: genes, disability, and design","author":"J Glover","year":"2006","unstructured":"Glover J (2006) Choosing children: genes, disability, and design. Oxford University Press, Oxford"},{"key":"1147_CR67","doi-asserted-by":"publisher","DOI":"10.7551\/mitpress\/13492.001.0001","volume-title":"CRISPR people: the science and ethics of editing humans","author":"HT Greely","year":"2021","unstructured":"Greely HT (2021) CRISPR people: the science and ethics of editing humans. MIT Press, Cambridge, MA; London, UK"},{"issue":"10","key":"1147_CR68","doi-asserted-by":"publisher","first-page":"4154","DOI":"10.1172\/JCI72992","volume":"124","author":"RM Gupta","year":"2014","unstructured":"Gupta RM, Musunuru K (2014) Expanding the genetic editing tool kit: ZFNs, TALENs, and CRISPR-Cas9. J Clin Investig 124(10):4154\u20134161. https:\/\/doi.org\/10.1172\/JCI72992","journal-title":"J Clin Investig"},{"issue":"4","key":"1147_CR71","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1111\/japp.12249","volume":"34","author":"C Gyngell","year":"2017","unstructured":"Gyngell C, Douglas T, Savulescu J (2017) The ethics of germline gene editing. J Appl Philosy 34(4):498\u2013513","journal-title":"J Appl Philosy"},{"key":"1147_CR72","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1136\/medethics-2018-105084","volume":"0","author":"C Gyngell","year":"2019","unstructured":"Gyngell C, Bowman-Smart H, Savulescu J (2019) Moral reasons to edit the human genome: picking up from the Nuffield report. J Med Ethics 0:1\u201310. https:\/\/doi.org\/10.1136\/medethics-2018-105084","journal-title":"J Med Ethics"},{"issue":"4","key":"1147_CR70","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1111\/bioe.12098","volume":"29","author":"C Gyngell","year":"2015","unstructured":"Gyngell C, Douglas T (2015) Stocking the genetic supermarket: reproductive genetic technologies and collective action problems. Bioethics 29(4):241\u2013250","journal-title":"Bioethics"},{"key":"1147_CR69","doi-asserted-by":"publisher","unstructured":"Guttinger S (2017) Trust in science: CRISPR-Cas9 and the ban on human germline editing. Sci Eng Eth 1\u201320. https:\/\/doi.org\/10.1007\/s11948-017-9931-1","DOI":"10.1007\/s11948-017-9931-1"},{"key":"1147_CR73","volume-title":"The future of human nature","author":"J Habermas","year":"2003","unstructured":"Habermas J (2003) The future of human nature. Polity Press, Cambridge"},{"key":"1147_CR74","volume":"83","author":"AL Hammerstein","year":"2019","unstructured":"Hammerstein AL, Eggel M, Biller-Andorno N (2019) Is selecting better than modifying? An investigation of arguments against germline gene editing as compared to preimplantation genetic diagnosis. BMC Med Eth 83:20","journal-title":"BMC Med Eth"},{"issue":"5\u20136","key":"1147_CR75","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1111\/1467-8519.00360","volume":"17","author":"M H\u00e4yry","year":"2003","unstructured":"H\u00e4yry M (2003) Philosophical arguments for and against human reproductive cloning. Bioethics 17(5\u20136):447\u2013460","journal-title":"Bioethics"},{"key":"1147_CR76","unstructured":"Howard T, Rifkin J (1977) Who should play God? The artificial creation of life and what it means for the future of the human race. Dell Publ. Co"},{"issue":"6","key":"1147_CR77","doi-asserted-by":"publisher","first-page":"1262","DOI":"10.1016\/j.cell.2014.05.010","volume":"157","author":"PD Hsu","year":"2014","unstructured":"Hsu PD, Lander ES, Zhang F (2014) Development and applications of CRISPR-Cas9 for genome engineering. Cell 157(6):1262\u20131278. https:\/\/doi.org\/10.1016\/j.cell.2014.05.010","journal-title":"Cell"},{"issue":"1","key":"1147_CR78","first-page":"25","volume":"32","author":"JB Hurlbut","year":"2015","unstructured":"Hurlbut JB, Saha K, Jasanoff S (2015) CRISPR democracy: gene editing and the need for inclusive deliberation. Issues Sci Technol 32(1):25\u201332","journal-title":"Issues Sci Technol"},{"issue":"11","key":"1147_CR79","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1038\/nbt.4000","volume":"35","author":"I Hyun","year":"2017","unstructured":"Hyun I, Osborn C (2017) Query the merits of embryo editing for reproductive research now. Nat Biotechnol 35(11):1023\u20131025. https:\/\/doi.org\/10.1038\/nbt.4000. PMID: 29121025","journal-title":"Nat Biotechnol"},{"key":"1147_CR80","doi-asserted-by":"crossref","unstructured":"Iltis AS, Hoover S, Matthews KRW (2021) Public and stakeholder engagement in developing human heritable genome editing policies: what does it mean and what should it mean? Front Political Sci 3. https:\/\/www.frontiersin.org\/article\/10.3389\/fpos.2021.730869","DOI":"10.3389\/fpos.2021.730869"},{"issue":"6271","key":"1147_CR81","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1126\/science.aad6778","volume":"351","author":"R Isasi","year":"2016","unstructured":"Isasi R, Kleiderman E, Knoppers BM (2016) Genetic technology regulation: editing policy to fit the genome? Science 351(6271):337\u2013339. https:\/\/doi.org\/10.1126\/science.aad6778","journal-title":"Science"},{"issue":"8","key":"1147_CR82","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1016\/j.molmed.2015.05.006","volume":"21","author":"T Ishii","year":"2015","unstructured":"Ishii T (2015) Germline genome-editing research and its socio-ethical implications. Trends Mol Med 21(8):473\u2013481. https:\/\/doi.org\/10.1016\/j.molmed.2015.05.006","journal-title":"Trends Mol Med"},{"issue":"12","key":"1147_CR83","doi-asserted-by":"publisher","first-page":"1186","DOI":"10.1038\/gim.2016.28","volume":"18","author":"AC Janssens","year":"2016","unstructured":"Janssens AC (2016) Designing babies through gene editing: science or science fiction? Genet Med 18(12):1186\u20131187. https:\/\/doi.org\/10.1038\/gim.2016.28","journal-title":"Genet Med"},{"issue":"12","key":"1147_CR84","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.1038\/s10038-020-0810-2","volume":"65","author":"A Jedwab","year":"2020","unstructured":"Jedwab A, Vears DF, Tse C, Gyngell C (2020) Genetics experience impacts attitudes towards germline gene editing: a survey of over 1500 members of the public. J Hum Genetics65(12):1055\u20131065","journal-title":"J Hum Genetics"},{"key":"1147_CR85","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1126\/science.1225829","volume":"337","author":"M Jinek","year":"2012","unstructured":"Jinek M, Chylinski K, Fonfara I, Hauer M, Doudna JA, Charpentier E (2012) Programmable dual\u2010RNA\u2010guided DNA endonuclease in adaptive bacterial immunity. Science 337:816\u2013821","journal-title":"Science"},{"issue":"4","key":"1147_CR86","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1016\/j.stemcr.2020.03.010","volume":"14","author":"EC Jonlin","year":"2020","unstructured":"Jonlin EC (2020) Informed consent for human embryo genome editing. Stem Cell Rep 14(4):530\u2013537. https:\/\/doi.org\/10.1016\/j.stemcr.2020.03.010","journal-title":"Stem Cell Rep"},{"issue":"2","key":"1147_CR87","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1093\/jmp\/22.2.125","volume":"22","author":"ET Juengst","year":"1997","unstructured":"Juengst ET (1997) Can enhancement be distinguished from prevention in genetic medicine? J Med Philos 22(2):125\u2013142","journal-title":"J Med Philos"},{"key":"1147_CR88","unstructured":"Juengst, ET, Moseley D (2019) Human enhancement. In: Zalta EN (ed.) The Stanford encyclopedia of philosophy (Summer 2019 Edition), Metaphysics Research Lab, Philosophy Department, Stanford University, Stanford"},{"issue":"6","key":"1147_CR89","doi-asserted-by":"publisher","first-page":"1424","DOI":"10.1016\/j.cell.2019.10.033","volume":"179","author":"E Karavani","year":"2019","unstructured":"Karavani E, Zuk O, Zeevi D, Barzilai N, Stefanis NC, Hatzimanolis A et al. (2019) Screening human embryos for polygenic traits has limited utility. Cell 179(6):1424\u20131435","journal-title":"Cell"},{"key":"1147_CR90","doi-asserted-by":"crossref","unstructured":"Kirksey E (2020) The Mutant Project: inside the global race to genetically modify humans. St. Martin\u2019s Press","DOI":"10.46692\/9781529217315"},{"issue":"2","key":"1147_CR91","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1080\/21507740.2022.2048733","volume":"13","author":"C Klingler","year":"2022","unstructured":"Klingler C, Wiese L, Arnason G, Ranisch R (2022) Public engagement with brain organoid research and application: lessons from genome editing. Am J Bioeth Neurosci 13(2):98\u2013100. https:\/\/doi.org\/10.1080\/21507740.2022.2048733","journal-title":"Am J Bioeth Neurosci"},{"issue":"6","key":"1147_CR92","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1038\/nbt.3884","volume":"35","author":"H K\u00f6nig","year":"2017","unstructured":"K\u00f6nig H (2017) The illusion of control in germline-engineering policy. Nat Biotechnol 35(6):502\u2013506. https:\/\/doi.org\/10.1038\/nbt.3884","journal-title":"Nat Biotechnol"},{"issue":"1","key":"1147_CR93","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1038\/nbt.4337","volume":"37","author":"S Krimsky","year":"2019","unstructured":"Krimsky S (2019) Ten ways in which He Jiankui violated ethics. Nat Biotechnol 37(1):19\u201320. https:\/\/doi.org\/10.1038\/nbt.4337","journal-title":"Nat Biotechnol"},{"issue":"1","key":"1147_CR94","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1056\/NEJMp1506446","volume":"373","author":"ES Lander","year":"2015","unstructured":"Lander ES (2015) Brave new genome. N Engl J Med 373(1):5\u20138","journal-title":"N Engl J Med"},{"issue":"7747","key":"1147_CR95","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1038\/d41586-019-00726-5","volume":"567","author":"ES Lander","year":"2019","unstructured":"Lander ES, Baylis F, Zhang F, Charpentier E, Berg P, Bourgain C et al. (2019) Adopt a moratorium on heritable genome editing. Nature 567(7747):165\u2013168. https:\/\/doi.org\/10.1038\/d41586-019-00726-5","journal-title":"Nature"},{"issue":"7544","key":"1147_CR96","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1038\/519410a","volume":"519","author":"E Lanphier","year":"2015","unstructured":"Lanphier E, Urnov F, Haecker SE, Werner M, Smolenski J (2015) Don\u2019t edit the human germ line. Nature 519(7544):410\u20131. https:\/\/doi.org\/10.1038\/519410a","journal-title":"Nature"},{"issue":"6","key":"1147_CR97","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1093\/jmp\/16.6.621","volume":"16","author":"M Lappe","year":"1991","unstructured":"Lappe M (1991) Ethical issues in manipulating the human germ line. J Med Philos 16(6):621\u2013639. https:\/\/doi.org\/10.1093\/jmp\/16.6.621","journal-title":"J Med Philos"},{"issue":"12","key":"1147_CR98","doi-asserted-by":"publisher","first-page":"1479","DOI":"10.1038\/s41556-019-0424-0","volume":"21","author":"RA Lea","year":"2019","unstructured":"Lea RA, Niakan KK (2019) Human germline genome editing. Nat Cell Biol 21(12):1479\u20131489. https:\/\/doi.org\/10.1038\/s41556-019-0424-0","journal-title":"Nat Cell Biol"},{"issue":"7573","key":"1147_CR99","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1038\/526310a","volume":"526","author":"H Ledford","year":"2015","unstructured":"Ledford H (2015) The landscape for human genome editing. Nature 526(7573):310\u2013311","journal-title":"Nature"},{"key":"1147_CR100","first-page":"9","volume":"1","author":"K Leon","year":"2003","unstructured":"Leon K (2003) Ageless bodies, happy souls: biotechnology and the pursuit of perfection. New Atlantis 1:9\u201328","journal-title":"New Atlantis"},{"issue":"1","key":"1147_CR101","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41392-019-0089-y","volume":"5","author":"H Li","year":"2020","unstructured":"Li H, Yang Y, Hong W, Huang M, Wu M, Zhao X (2020) Applications of genome editing technology in the targeted therapy of human diseases: mechanisms, advances and prospects. Signal Transduct Target Ther 5(1):1\u201323","journal-title":"Signal Transduct Target Ther"},{"issue":"2","key":"1147_CR102","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1093\/genetics\/129.2.513","volume":"129","author":"WH Li","year":"1991","unstructured":"Li WH, Sadler LA (1991) Low nucleotide diversity in man. Genetics 129(2):513\u201323","journal-title":"Genetics"},{"issue":"5","key":"1147_CR103","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1007\/s13238-015-0153-5","volume":"6","author":"P Liang","year":"2015","unstructured":"Liang P, Xu Y, Zhang X et al. (2015) CRISPR\/Cas9-mediated gene editing in human tripronuclear zygotes. Protein Cell 6(5):363\u2013372","journal-title":"Protein Cell"},{"issue":"3","key":"1147_CR104","doi-asserted-by":"publisher","first-page":"dev175778","DOI":"10.1242\/dev.175778","volume":"146","author":"R Lovell-Badge","year":"2019","unstructured":"Lovell-Badge R (2019) CRISPR babies: a view from the centre of the storm. Development 146(3):dev175778","journal-title":"Development"},{"key":"1147_CR16","volume-title":"The ethics of the new eugenics","year":"2014","unstructured":"MacKellar C, Bechtel C eds. (2014) The ethics of the new eugenics. Berghahn Books, New York, Oxford"},{"issue":"1","key":"1147_CR105","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1111\/bioe.12662","volume":"34","author":"A McGee","year":"2020","unstructured":"McGee A (2020) Using the therapy and enhancement distinction in law and policy. Bioethics 34(1):70\u201380","journal-title":"Bioethics"},{"key":"1147_CR106","first-page":"757","volume":"50","author":"TR Melillo","year":"2017","unstructured":"Melillo TR (2017) Gene editing and the rise of designer babies. Vand J Trans Law 50:757\u2013790","journal-title":"Vand J Trans Law"},{"issue":"12","key":"1147_CR107","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1080\/15265161.2015.1103813","volume":"15","author":"H Mertes","year":"2015","unstructured":"Mertes H, Pennings G (2015) Modification of the embryo\u2019s genome: more useful in research than in the clinic. Am J Bioeth 15(12):52\u201353. https:\/\/doi.org\/10.1080\/15265161.2015.1103813","journal-title":"Am J Bioeth"},{"issue":"1","key":"1147_CR110","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1093\/bmb\/ldx002","volume":"122","author":"JJ Mulvihill","year":"2017","unstructured":"Mulvihill JJ, Capps B, Joly Y, Lysaght T, Zwart HAE, Chadwick R, International Human Genome Organisation Committee of Ethics Law and Society (2017) Ethical issues of CRISPR technology and gene editing through the lens of solidarity. Br Med Bull 122(1):17\u201329. https:\/\/doi.org\/10.1093\/bmb\/ldx002","journal-title":"Br Med Bull"},{"key":"1147_CR111","unstructured":"Musunuru K (2019) The CRISPR generation: the story of the world\u2019s first gene-edited babies. BookBaby."},{"key":"1147_CR11","volume-title":"International summit on human gene editing: a global discussion","author":"National Academies of Sciences, Engineering, and Medicine","year":"2015","unstructured":"National Academies of Sciences, Engineering, and Medicine (2015) International summit on human gene editing: a global discussion. The National Academies Press, Washington"},{"key":"1147_CR112","unstructured":"National Academy of Sciences, National Academy of Medicine (2017) Human genome editing: science, ethics and governance. The National Academies Press, Washington, DC"},{"key":"1147_CR18","volume-title":"Heritable human genome editing","author":"National Academy of Medicine, National Academy of Sciences, and the Royal Society","year":"2020","unstructured":"National Academy of Medicine, National Academy of Sciences, and the Royal Society (2020) Heritable human genome editing. The National Academies Press, Washington, DC"},{"key":"1147_CR113","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1016\/j.csbj.2020.03.014","volume":"18","author":"E Niemiec","year":"2020","unstructured":"Niemiec E, Howard HC (2020) Ethical issues related to research on genome editing in human embryos. Comput Struct Biotechnol J 18:887\u2013896","journal-title":"Comput Struct Biotechnol J"},{"key":"1147_CR14","volume-title":"Second International Summit on human genome editing: continuing the global discussion: proceedings of a workshop in brief","author":"National Academies of Sciences, Engineering, and Medicine","year":"2019","unstructured":"National Academies of Sciences, Engineering, and Medicine (2019) Second International Summit on human genome editing: continuing the global discussion: proceedings of a workshop in brief. The National Academies Press, Washington"},{"issue":"4","key":"1147_CR114","doi-asserted-by":"publisher","first-page":"836","DOI":"10.1016\/j.cell.2014.01.027","volume":"156","author":"Y Niu","year":"2014","unstructured":"Niu Y, Shen B, Cui Y, Chen Y, Wang J, Wang L et al. (2014) Generation of gene-modified cynomolgus monkey via Cas9\/RNA-mediated gene targeting in one-cell embryos. Cell 156(4):836\u2013843","journal-title":"Cell"},{"issue":"1","key":"1147_CR115","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1111\/bioe.12705","volume":"34","author":"A Nordberg","year":"2020","unstructured":"Nordberg A, Minssen T, Feeney O, de Miguel Beriain I, Galvagni L, Wartiovaara K (2020) Regulating germline editing in assisted reproductive technology: an EU cross\u2010disciplinary perspective. Bioethics 34(1):16\u201332","journal-title":"Bioethics"},{"key":"1147_CR116","unstructured":"Nuffield Council on Bioethics (2016) Genome Editing: an ethical review. https:\/\/www.nuffieldbioethics.org\/publications\/genome-editing-an-ethical-review"},{"key":"1147_CR117","doi-asserted-by":"crossref","unstructured":"Nuffield Council on Bioethics (2018) Genome editing and human reproduction: social and ethical issues. http:\/\/nuffieldbioethics.org\/project\/genome-editing-human-reproduction","DOI":"10.1515\/jwiet-2019-0012"},{"key":"1147_CR118","volume-title":"Prenatal testing and disability rights","author":"E Parens","year":"2000","unstructured":"Parens E, Asch A (2000) The disability rights critique of prenatal testing: reflections and recommendations. In: Parens E, Asch A (eds.) Prenatal testing and disability rights. Georgetown University Press, Washington"},{"key":"1147_CR119","unstructured":"Parliamentary Assembly (1982) Recommendation on genetic engineering. In Recommendation 934. Council of Europe"},{"key":"1147_CR120","doi-asserted-by":"crossref","unstructured":"Paul D (2005) Genetic engineering and eugenics: the uses of history. In: Baillie HW, Casey TK (eds.) Is human nature obsolete? Genetics, bioengineering, and the future of the human condition. MIT Press, Cambridge Mass","DOI":"10.7551\/mitpress\/3977.003.0008"},{"key":"1147_CR121","doi-asserted-by":"publisher","first-page":"R198","DOI":"10.1093\/hmg\/ddr384","volume":"20","author":"JF Peden","year":"2011","unstructured":"Peden JF, Farrall M (2011) Thirty-five common variants for coronary artery disease: the fruits of much collaborative labour. Hum Mol Genet 20:R198\u2013205","journal-title":"Hum Mol Genet"},{"issue":"10","key":"1147_CR122","doi-asserted-by":"publisher","first-page":"947","DOI":"10.1056\/NEJMra1800729","volume":"380","author":"MH Porteus","year":"2019","unstructured":"Porteus MH (2019) A new class of medicines through DNA editing. New Engl J Med 380(10):947\u2013959. https:\/\/doi.org\/10.1056\/NEJMra1800729","journal-title":"New Engl J Med"},{"key":"1147_CR15","volume-title":"Enhancing human traits: ethical and social implications","year":"1998","unstructured":"Parens ET (Ed.) (1998) Enhancing human traits: ethical and social implications. Georgetown University Press, Washington, DC"},{"issue":"1","key":"1147_CR123","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1111\/bioe.12608","volume":"34","author":"N Primc","year":"2020","unstructured":"Primc N (2020) Do we have a right to an unmanipulated genome? The human genome as the common heritage of mankind Bioethics 34(1):41\u201348","journal-title":"Bioethics"},{"key":"1147_CR124","volume-title":"Fabricated man: the ethics of genetic control","author":"P Ramsey","year":"1970","unstructured":"Ramsey P (1970) Fabricated man: the ethics of genetic control. Yale University Press, New Haven"},{"issue":"12","key":"1147_CR125","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1080\/15265161.2017.1388875","volume":"17","author":"R Ranisch","year":"2017","unstructured":"Ranisch R (2017) Germline genome editing and the functions of consent. Am J Bioeth 17(12):27\u201329","journal-title":"Am J Bioeth"},{"key":"1147_CR126","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1111\/bioe.12635","volume":"34","author":"R Ranisch","year":"2020","unstructured":"Ranisch R (2020) Germline genome editing versus preimplantation genetic diagnosis: Is there a case in favour of germline interventions? Bioethics 34:60\u201369. https:\/\/doi.org\/10.1111\/bioe.12635","journal-title":"Bioethics"},{"issue":"1","key":"1147_CR127","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1111\/bioe.12709","volume":"34","author":"R Ranisch","year":"2020","unstructured":"Ranisch R, Ehni HJ (2020) Fading red lines? Bioethics of germline genome editing. Bioethics 34(1):3\u20136. https:\/\/doi.org\/10.1111\/bioe.12709","journal-title":"Bioethics"},{"issue":"1","key":"1147_CR128","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1089\/crispr.2019.0040","volume":"3","author":"R Ranisch","year":"2020","unstructured":"Ranisch R, Rudolph T, Cremer HJ, Knoepffler N (2020) Ordo-responsibility for germline gene editing. CRISPR J 3(1):37\u201343","journal-title":"CRISPR J"},{"key":"1147_CR129","doi-asserted-by":"crossref","unstructured":"Ranisch R (2021) When CRISPR meets fantasy: transhumanism and the military in the age of gene editing. In: Transhumanism: the proper guide to a posthuman condition or a dangerous idea?. Springer, Cham, pp. 111\u2013120","DOI":"10.1007\/978-3-030-56546-6_7"},{"key":"1147_CR130","doi-asserted-by":"crossref","unstructured":"Ranisch R, Sorgner SL (2014) Introducing post-and transhumanism. In: Ranisch & Sorgner (eds.) Post-and transhumanism: an introduction. pp. 7\u201327. Peter Lang Group AG, Switzerland","DOI":"10.3726\/978-3-653-05076-9"},{"key":"1147_CR131","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1007\/s11673-019-09906-4","volume":"16","author":"VL Raposo","year":"2019","unstructured":"Raposo VL (2019) Gene editing, the mystic threat to human dignity. Bioeth Inq 16:249\u2013257. https:\/\/doi.org\/10.1007\/s11673-019-09906-4","journal-title":"Bioeth Inq"},{"key":"1147_CR132","unstructured":"Regalado A (2018) EXCLUSIVE: Chinese scientists are creating CRISPR babies. MIT Technol Rev. https:\/\/www.technologyreview.com\/s\/612458\/exclusive-chinese-scientists-are-creating-crispr-babies\/. Accessed 4 Aug 2021"},{"issue":"1","key":"1147_CR133","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1080\/20502877.2018.1441669","volume":"24","author":"C Rehmann-Sutter","year":"2018","unstructured":"Rehmann-Sutter C (2018) Why human germline editing is more problematic than selecting between embryos: ethically considering intergenerational relationships. New Bioeth 24(1):9\u201325. https:\/\/doi.org\/10.1080\/20502877.2018.1441669","journal-title":"New Bioeth"},{"issue":"1","key":"1147_CR134","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1093\/jmp\/19.1.23","volume":"19","author":"D Resnik","year":"1994","unstructured":"Resnik D (1994) Debunking the slippery slope argument against human germ-line gene therapy. J Med Philos 19(1):23\u201340. https:\/\/doi.org\/10.1093\/jmp\/19.1.23","journal-title":"J Med Philos"},{"issue":"3","key":"1147_CR135","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1076\/jmep.23.3.303.2581","volume":"23","author":"G Richter","year":"1998","unstructured":"Richter G, Bacchetta MD (1998) Interventions in the human genome: some moral and ethical considerations. J Med Philos 23(3):303\u2013317. https:\/\/doi.org\/10.1076\/jmep.23.3.303.2581","journal-title":"J Med Philos"},{"key":"1147_CR136","doi-asserted-by":"publisher","first-page":"1072","DOI":"10.1111\/bioe.12663","volume":"33","author":"T Rulli","year":"2019","unstructured":"Rulli T (2019) Reproductive CRISPR does not cure disease. Bioethics 33:1072\u20131082","journal-title":"Bioethics"},{"key":"1147_CR137","doi-asserted-by":"publisher","DOI":"10.4159\/9780674043060","volume-title":"The case against perfection: ethics in the age of genetic engineering","author":"M Sandel","year":"2007","unstructured":"Sandel M (2007) The case against perfection: ethics in the age of genetic engineering. The Belknap Press of Harvard University Press, Cambridge"},{"issue":"5\u20136","key":"1147_CR138","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1111\/1467-8519.00251","volume":"15","author":"J Savulescu","year":"2001","unstructured":"Savulescu J (2001) Procreative beneficence: why we should select the best children. Bioethics 15(5\u20136):413\u201326","journal-title":"Bioethics"},{"key":"1147_CR139","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1007\/s13238-015-0184-y","volume":"6","author":"J Savulescu","year":"2015","unstructured":"Savulescu J, Pugh J, Douglas T, Gyngell C (2015) The moral imperative to continue gene editing research on human embryos. Protein Cell 6:476\u2013479","journal-title":"Protein Cell"},{"key":"1147_CR140","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.gde.2016.07.008","volume":"41","author":"A Scally","year":"2016","unstructured":"Scally A (2016) The mutation rate in human evolution and demographic inference. Curr Opin Genet Dev 41:36\u201343","journal-title":"Curr Opin Genet Dev"},{"issue":"3","key":"1147_CR141","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1007\/s11019-020-09947-2","volume":"23","author":"GO Schaefer","year":"2020","unstructured":"Schaefer GO (2020) Can reproductive genetic manipulation save lives? Med Health Care Philos 23(3):381\u2013386","journal-title":"Med Health Care Philos"},{"issue":"6351","key":"1147_CR142","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1126\/science.aan3708","volume":"357","author":"DA Scheufele","year":"2017","unstructured":"Scheufele DA, Xenos MA, Howell EL, Rose KM, Brossard D, Hardy BW (2017) U.S. attitudes on human genome editing. Science 357(6351):553\u2013554. https:\/\/doi.org\/10.1126\/science.aan3708","journal-title":"Science"},{"key":"1147_CR143","doi-asserted-by":"publisher","unstructured":"Scheufele DA, Krause NM, Freiling I, Brossard D (2021) What we know about effective public engagement on CRISPR and beyond. Proc Natl Acad Sci USA 118(22). https:\/\/doi.org\/10.1073\/pnas.2004835117","DOI":"10.1073\/pnas.2004835117"},{"issue":"10","key":"1147_CR144","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1038\/nrg2453","volume":"9","author":"JL Scully","year":"2008","unstructured":"Scully JL (2008) Disability and genetics in the era of genomic medicine. Nat Rev Genet 9(10):797\u2013802","journal-title":"Nat Rev Genet"},{"issue":"1","key":"1147_CR145","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1111\/bioe.12607","volume":"34","author":"S Segers","year":"2020","unstructured":"Segers S, Mertes H (2020) Does human genome editing reinforce or violate human dignity? Bioethics 34(1):33\u201340","journal-title":"Bioethics"},{"issue":"9421","key":"1147_CR146","doi-asserted-by":"publisher","first-page":"1633","DOI":"10.1016\/S0140-6736(04)16209-0","volume":"363","author":"K Sermon","year":"2004","unstructured":"Sermon K, Van Steirteghem A, Liebaers I (2004) Preimplantation genetic diagnosis. Lancet 363(9421):1633\u20131641. https:\/\/doi.org\/10.1016\/S0140-6736(04)16209-0","journal-title":"Lancet"},{"key":"1147_CR147","doi-asserted-by":"publisher","DOI":"10.4324\/9780203640098","volume-title":"Disability rights and wrongs","author":"T Shakespeare","year":"2006","unstructured":"Shakespeare T (2006) Disability rights and wrongs. Routledge, London"},{"issue":"1","key":"1147_CR148","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1111\/1758-5899.12123","volume":"5","author":"C Shulman","year":"2014","unstructured":"Shulman C, Bostrom N (2014) Embryo selection for cognitive enhancement: curiosity or game-changer? Glob Policy 5(1):85\u201392. https:\/\/doi.org\/10.1111\/1758-5899.12123","journal-title":"Glob Policy"},{"key":"1147_CR149","volume-title":"Remaking Eden: cloning and beyond in a brave new world","author":"LM Silver","year":"1997","unstructured":"Silver LM (1997) Remaking Eden: cloning and beyond in a brave new world. William Morrow, New York, NY"},{"key":"1147_CR150","unstructured":"Sinsheimer RL (1969). The prospect for designed genetic change. Am Sci, 57(1):134\u2013142. http:\/\/www.jstor.org\/stable\/27828443"},{"issue":"12","key":"1147_CR151","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1080\/15265161.2015.1103816","volume":"15","author":"J Smolenski","year":"2015","unstructured":"Smolenski J (2015) Crispr\/cas9 and germline modification: new difficulties in obtaining informed consent. Am J Bioeth 15(12):35\u201337","journal-title":"Am J Bioeth"},{"issue":"2","key":"1147_CR152","first-page":"309","volume":"26","author":"S Soini","year":"2007","unstructured":"Soini S (2007) Preimplantation genetic diagnosis (PGD) in Europe: diversity of legislation a challenge to the community and its citizens. Med Law 26(2):309\u2013323","journal-title":"Med Law"},{"key":"1147_CR153","doi-asserted-by":"crossref","unstructured":"Sorgner SL (2018) Genes, CRISPR\/Cas 9, and posthumans. In: Sinaci M and Sorgner SL (eds.) Ethics of emerging biotechnologies, pp. 5\u201317. Trivent Publishing","DOI":"10.22618\/TP.AEBIO.20181.192002"},{"key":"1147_CR154","first-page":"1","volume":"19","author":"R Sparrow","year":"2021","unstructured":"Sparrow R (2021) Human germline genome editing: on the nature of our reasons to genome edit Am J Bioeth 19:1\u201312","journal-title":"Am J Bioeth"},{"issue":"4","key":"1147_CR155","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1016\/j.stem.2018.01.004","volume":"22","author":"J Steffann","year":"2018","unstructured":"Steffann J, Jouannet P, Bonnefont JP, Chneiweiss H, Frydman N (2018) Could failure in preimplantation genetic diagnosis justify editing the human embryo genome? Cell Stem Cell 22(4):481\u2013482. https:\/\/doi.org\/10.1016\/j.stem.2018.01.004","journal-title":"Cell Stem Cell"},{"key":"1147_CR156","doi-asserted-by":"publisher","first-page":"1871","DOI":"10.15252\/embr.201745246","volume":"18","author":"P Sykora","year":"2017","unstructured":"Sykora P, Caplan A (2017) The Council of Europe should not reaffirm the ban on germline genome editing in humans. EMBO Rep 18:1871\u20131872. https:\/\/doi.org\/10.15252\/embr.201745246","journal-title":"EMBO Rep"},{"key":"1147_CR12","volume-title":"Universal declaration on the human genome and human rights","author":"UNESCO","year":"1997","unstructured":"UNESCO (1997) Universal declaration on the human genome and human rights. UNESCO, Paris"},{"issue":"9","key":"1147_CR157","doi-asserted-by":"publisher","first-page":"1777","DOI":"10.1093\/humrep\/dey257","volume":"33","author":"I van Dijke","year":"2018","unstructured":"van Dijke I, Bosch L, Bredenoord AL, Cornel M, Repping S, Hendriks S (2018) The ethics of clinical applications of germline genome modification: a systematic review of reasons Hum Reprod 33(9):1777\u20131796","journal-title":"Hum Reprod"},{"issue":"4","key":"1147_CR158","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1093\/humupd\/dmw005","volume":"22","author":"R Vassena","year":"2016","unstructured":"Vassena R, Heindryckx B, Peco R, Pennings G, Raya A, Sermon K, Veiga A (2016) Genome engineering through CRISPR\/Cas9 technology in the human germline and pluripotent stem cells. Hum Reprod Update 22(4):411\u2013419. https:\/\/doi.org\/10.1093\/humupd\/dmw005","journal-title":"Hum Reprod Update"},{"issue":"5507","key":"1147_CR159","doi-asserted-by":"publisher","first-page":"1304","DOI":"10.1126\/science.1058040","volume":"291","author":"JC Venter","year":"2001","unstructured":"Venter JC et al. (2001) The sequence of the human genome. Science 291(5507):1304\u201351","journal-title":"Science"},{"issue":"4","key":"1147_CR160","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1089\/crispr.2021.0043","volume":"4","author":"L Walters","year":"2021","unstructured":"Walters L, Cook-Deegan RM, Adashi EY (2021) Governing heritable human genome editing: a textual history and a proposal for the future. CRISPR J 4(4):469\u2013476","journal-title":"CRISPR J"},{"key":"1147_CR161","doi-asserted-by":"publisher","unstructured":"Wang H, Yang H (2019) Gene-edited babies: what went wrong and what could go wrong. PLoS Biol 17(4). https:\/\/doi.org\/10.1371\/journal.pbio.3000224","DOI":"10.1371\/journal.pbio.3000224"},{"key":"1147_CR163","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1093\/bfgp\/elr008","volume":"10","author":"E Wheeler","year":"2011","unstructured":"Wheeler E, Barroso I (2011) Genome-wide association studies and type 2 diabetes. Brief Funct Genom 10:52\u201360","journal-title":"Brief Funct Genom"},{"key":"1147_CR164","unstructured":"WHO (2019) Statement on governance and oversight of human genome editing. https:\/\/www.who.int\/news\/item\/26-07-2019-statement-on-governance-and-oversight-of-human-genome-editing"},{"key":"1147_CR165","unstructured":"WHO (2021) Human genome editing: position paper. https:\/\/www.who.int\/publications\/i\/item\/9789240030404"},{"issue":"6","key":"1147_CR166","doi-asserted-by":"publisher","first-page":"890","DOI":"10.1038\/s41591-019-0473-8","volume":"25","author":"DP Wolf","year":"2019","unstructured":"Wolf DP, Mitalipov PA, Mitalipov SM (2019) Principles of and strategies for germline gene therapy. Nat Med 25(6):890\u2013897","journal-title":"Nat Med"},{"key":"1147_CR167","doi-asserted-by":"publisher","unstructured":"Zhang F (2019) Development of CRISPR-Cas systems for genome editing and beyond. Q Rev Biophys 52. https:\/\/doi.org\/10.1017\/s0033583519000052","DOI":"10.1017\/s0033583519000052"}],"container-title":["Humanities and Social Sciences Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41599-022-01147-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41599-022-01147-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41599-022-01147-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,20]],"date-time":"2023-11-20T06:45:01Z","timestamp":1700462701000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41599-022-01147-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4,20]]},"references-count":167,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["1147"],"URL":"https:\/\/doi.org\/10.1057\/s41599-022-01147-y","relation":{},"ISSN":["2662-9992"],"issn-type":[{"value":"2662-9992","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,4,20]]},"assertion":[{"value":"6 August 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 March 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 April 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"An ethical approval is not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"This article does not contain any studies with human participants performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}],"article-number":"139"}}